Kantar Health and Nokia Launch Diabetes Lifestyle Study

In the US, Kantar Health has partnered with tech giant Nokia to develop a longitudinal cohort study, to improve understanding of the impact of 'lifestyle therapy' on diabetes treatment and patient outcomes.

Using a combination of biometric and longitudinal, real-world data, the study will aim to provide a 360-degree view of diabetic patients. Kantar Health will manage the study design and execution, while Nokia will use its technology to generate biometric data and facilitate study delivery. The first data analysis of research findings is expected by the Fall of 2017, with final research findings completed and announced by the Spring of 2018.

Cedric Hutchings, VP of Digital Health at Nokia, says the global healthcare community must continue to cultivate data-based consumer insights to form a more complete picture of the modern patient. Geneviève Bonnelye, MD, Kantar Health, adds: 'Lifestyle therapy, including changes in nutrition, physical activity, sleep and nicotine use, is an essential component of type 2 diabetes treatment. However, there's a lack of longitudinal patient data about the disease's impact on weight, activity level, sleep and blood pressure, as well as limited evidence on how treatment management is affecting patients' loss or gain of weight. Our landmark study with Nokia should help fill these data gaps and ultimately improve patient care'.

Web sites: www.kantarhealth.com and www.nokia.com .